Women's health Archives

Clinical Articles

Removing MHT warnings is long overdue – so why are experts worried?

The FDA has done the right thing, the wrong way, and probably for the wrong reason – should we follow suit?

Clinical Articles

Women told they have dense breasts are more confused & anxious, new study finds

BreastScreen Australia now recommends women be informed of their breast density, but what will the impact be?

Podcasts

Interpreting the FDA’s MHT decision: What clinicians should know

Prof Rodney Baber AM breaks down the FDA’s MHT decision and provides a clear, evidence-based perspective on what matters for safe and balanced menopause care.

Podcasts

Understanding vaginal microbiome shifts in clinical practice

Dr Rebecca Mackenzie-Proctor outlines how hormonal shifts, antibiotics and lifestyle factors influence vaginal microbiome health and shares practical, evidence-aligned ways clinicians can support patients with recurrent symptoms.

Clinical Articles

New cervical screening guidelines: Your questions answered

Australian Centre for the Prevention of Cervical Cancer executive director Professor Marion Saville answers GPs’ questions about putting the guidelines into practice

Podcasts

Choosing the right oestrogen in everyday prescribing

Prof Deborah Bateson AM explains on how different oestrogens work, how they affect safety and metabolism, and how this knowledge supports better contraceptive and MHT choices.

Podcasts

Breast density, oncoplastic choices and axilla decisions

In today’s episode, Dr Susan Hawes discusses breast density, modern oncoplastic techniques and the evolving approach to axillary management.

Podcasts

Obstructive sleep apnoea is different in women: What you might be missing

In today's episode, Dr Alison Wimms highlights how hormonal changes and subtle symptoms make sleep apnoea in women easy to miss in clinical practice.

Podcasts

Fetal Rhesus screening: What healthcare professionals need to know

This episode explores the evolving landscape of fetal Rhesus screening in pregnancy care, featuring expert insights from A/Prof Marina Berbic and Jessica Clarke. Learn how advances in cell-free DNA testing are reshaping anti-D immunoglobulin use, why updated national guidelines matter, and what healthcare professionals need to know about ordering, timing, and interpreting results.

Podcasts

Recognising and managing hypermobility and EDS in general practice

Ehlers-Danlos syndrome and hypermobility are more common than you think. Dr Jason Lam and physiotherapist Leanne Scown unpack the key signs to look for, why early recognition matters, and how healthcare professionals can lead coordinated, effective care for these often-overlooked patients

Podcasts

POTS in Ehlers-Danlos syndrome

Marie Claire Seely discusses how primary care clinicians can better recognise, assess and support patients living with POTS and other forms of dysautonomia.

Podcasts

Menopausal hormone therapy and its cardiovascular benefits

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

Women's health

Removing MHT warnings is long overdue – so why are experts worried?

The FDA has done the right thing, the wrong way, and probably for the wrong reason – should we follow suit?

Women told they have dense breasts are more confused & anxious, new study finds

BreastScreen Australia now recommends women be informed of their breast density, but what will the impact be?

Interpreting the FDA’s MHT decision: What clinicians should know

Prof Rodney Baber AM breaks down the FDA’s MHT decision and provides a clear, evidence-based perspective on what matters for safe and balanced menopause care.

Understanding vaginal microbiome shifts in clinical practice

Dr Rebecca Mackenzie-Proctor outlines how hormonal shifts, antibiotics and lifestyle factors influence vaginal microbiome health and shares practical, evidence-aligned ways clinicians can support patients with recurrent symptoms.

New cervical screening guidelines: Your questions answered

Australian Centre for the Prevention of Cervical Cancer executive director Professor Marion Saville answers GPs’ questions about putting the guidelines into practice

Choosing the right oestrogen in everyday prescribing

Prof Deborah Bateson AM explains on how different oestrogens work, how they affect safety and metabolism, and how this knowledge supports better contraceptive and MHT choices.

Breast density, oncoplastic choices and axilla decisions

In today’s episode, Dr Susan Hawes discusses breast density, modern oncoplastic techniques and the evolving approach to axillary management.

Obstructive sleep apnoea is different in women: What you might be missing

In today's episode, Dr Alison Wimms highlights how hormonal changes and subtle symptoms make sleep apnoea in women easy to miss in clinical practice.

Fetal Rhesus screening: What healthcare professionals need to know

Recognising and managing hypermobility and EDS in general practice

Ehlers-Danlos syndrome and hypermobility are more common than you think. Dr Jason Lam and physiotherapist Leanne Scown unpack the key signs to look for, why early recognition matters, and how healthcare professionals can lead coordinated, effective care for these often-overlooked patients

POTS in Ehlers-Danlos syndrome

Marie Claire Seely discusses how primary care clinicians can better recognise, assess and support patients living with POTS and other forms of dysautonomia.

Menopausal hormone therapy and its cardiovascular benefits

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

Get the app

Site

Company

Connect

Legal

Healthed

Women's health

The FDA has done the right thing, the wrong way, and probably for the wrong reason – should we follow suit?

BreastScreen Australia now recommends women be informed of their breast density, but what will the impact be?

Prof Rodney Baber AM breaks down the FDA’s MHT decision and provides a clear, evidence-based perspective on what matters for safe and balanced menopause care.

Dr Rebecca Mackenzie-Proctor outlines how hormonal shifts, antibiotics and lifestyle factors influence vaginal microbiome health and shares practical, evidence-aligned ways clinicians can support patients with recurrent symptoms.

Australian Centre for the Prevention of Cervical Cancer executive director Professor Marion Saville answers GPs’ questions about putting the guidelines into practice

Prof Deborah Bateson AM explains on how different oestrogens work, how they affect safety and metabolism, and how this knowledge supports better contraceptive and MHT choices.

In today’s episode, Dr Susan Hawes discusses breast density, modern oncoplastic techniques and the evolving approach to axillary management.

In today's episode, Dr Alison Wimms highlights how hormonal changes and subtle symptoms make sleep apnoea in women easy to miss in clinical practice.

Ehlers-Danlos syndrome and hypermobility are more common than you think. Dr Jason Lam and physiotherapist Leanne Scown unpack the key signs to look for, why early recognition matters, and how healthcare professionals can lead coordinated, effective care for these often-overlooked patients

Marie Claire Seely discusses how primary care clinicians can better recognise, assess and support patients living with POTS and other forms of dysautonomia.

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

Get the app

Site

Company

Connect

Legal

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed